Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1
dc.conference.date | SEP 19-OCT 18, 2020 | |
dc.conference.title | ESMO Virtual Congress | |
dc.contributor.author | Lu, Y-S. | |
dc.contributor.author | Chiu, J. | |
dc.contributor.author | Airoldi, M. | |
dc.contributor.author | Margeli Vila, M. | |
dc.contributor.author | Ponce Lorenzo, J. | |
dc.contributor.author | Ghaznawi, F. | |
dc.contributor.author | Gaudenzi, F. | |
dc.contributor.author | Ridolfi, A. | |
dc.contributor.author | Lorenzo, I. | |
dc.contributor.author | Ruiz Borrego, M. | |
dc.contributor.authoraffiliation | [Lu, Y-S.] Natl Taiwan Univ Hosp, Med Oncol, Taipei, Taiwan | |
dc.contributor.authoraffiliation | [Chiu, J.] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China | |
dc.contributor.authoraffiliation | [Airoldi, M.] San Giovanni Battista Hosp, Dept Med Oncol, Turin, Italy | |
dc.contributor.authoraffiliation | [Margeli Vila, M.] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain | |
dc.contributor.authoraffiliation | [Ponce Lorenzo, J.] Univ Gen Hosp Alicante, Dept Med Oncol, Alicante, Spain | |
dc.contributor.authoraffiliation | [Ghaznawi, F.] Novartis Pharmaceut, Oncol, E Hanover, NJ USA | |
dc.contributor.authoraffiliation | [Gaudenzi, F.] Novartis Pharma AG, Oncol, Basel, Switzerland | |
dc.contributor.authoraffiliation | [Ridolfi, A.] Novartis Pharma SAS, Oncol, Paris, France | |
dc.contributor.authoraffiliation | [Lorenzo, I.] Novartis Pharma SAS, Oncol, Paris, France | |
dc.contributor.authoraffiliation | [Ruiz Borrego, M.] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain | |
dc.contributor.funder | Novartis Pharmaceuticals Corporation | |
dc.date.accessioned | 2025-01-07T15:32:10Z | |
dc.date.available | 2025-01-07T15:32:10Z | |
dc.date.issued | 2020-09-01 | |
dc.identifier.doi | 10.1016/j.annonc.2020.08.403 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420403990/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27217 | |
dc.identifier.wosID | 573469100301 | |
dc.issue.number | 4 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S363-S363 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1 | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 31 | |
dc.wostype | Meeting Abstract |